Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.
Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells.
CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
A Systematic Review of Health-related Work Outcome Measures, and Quality Criteria based Evaluations of their Psychometric Properties.
Role of metabolism in neurodegenerative disorders.
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.
Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis.
Assessing Functional Decline in Neurological Diseases Clinical Trials: Duration of Follow-Up - The Case of Multiple Sclerosis.
Medium-dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.
Optic Nerve.
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.
Cancer co-occurrence patterns in Parkinson's disease and multiple sclerosis-Do they mirror immune system imbalances?
Accuracy of the Fluorescence-Activated Cell Sorting Assay for the Aquaporin-4 Antibody (AQP4-Ab): Comparison with the Commercial AQP4-Ab Assay Kit.
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.
Distribution of Hepatitis C virus genotypes in city of Mashhad, North-east of Iran.
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.
Diffusivity in multiple sclerosis lesions: At the cutting edge?
Brain stiffness increases with myelin content.
A Case of Optic Neuritis Concomitant with Pituitary Tumor during Pregnancy.
Retinal nerve fiber layer thickness by Stratus and Cirrus OCT in retrobulbar optic neuritis and nonarteritic ischemic optic neuropathy.
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.
Revisiting the role of erythropoietin for treatment of ocular disorders.
Pages
« first
‹ previous
…
721
722
723
724
725
726
727
728
729
…
next ›
last »